MaxCyte (MXCT) Q3 2026 Earnings Call Transcript
Management sees its Akron Bio deal accelerating the path to profitability ahead.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Record plunge in investor loans as tax overhaul hits property market
Labor’s tax changes, along with high interest rates and falling prices, are now hitting the property market. But one sector is showing surprising growth.
Record plunge in investor loans as tax overhaul hits property market
Labor’s tax changes, along with high interest rates and falling prices, are now hitting the property market. But one sector is showing surprising growth.
Sirsa records highest air quality index of 403, Delhi logs 299
The concentration of highly polluted cities across Haryana, Uttar Pradesh, and Delhi highlights the growing air quality challenge in northern India.
Darling: 3 Key Takeaways for Long-Term Investors
Accounting timing masks the fuel segment's true earnings power, but management expects deferred profits to resurface as margins normalize.
- Darling reduced net debt by $420 million and repurchased $76 million of shares
- Management discussed impact of hedging losses and feedstock rules on Diamond Green Diesel
- Darling confident in global demand for feed and protein ingredients and biofuel mandates
Nine Energy (NINE) Q3 2026 Earnings Call Transcript
Cementing growth outpaced rig counts as management pivots toward higher returns.
PSX: selling at bourse, KSE-100 down over 500 points
Selling was observed at the Pakistan Stock Exchange (PSX) amid concerns about ongoing attacks on shipping in the Strait of Hormuz, with the benchmark KSE-100 Index shedding over 500 points during the…